July 29, 2026

Each tablet that is not produced is a capsule order and each capsule order requires an empty capsule before the first milligram of active ingredient is placed in the capsule. However, India’s low bulk capsule production market is concentrated with just a few large-scale manufacturers, with mid-size formulation companies and nutraceutical brands waiting for days for orders which would fill their weeks in a free competitive market. It is the space where India businessmen can create an empty capsule manufacturing plant that can be sold to other business-to-business players – not branded as a consumer product. It’s packaging-adjacent manufacturing — not sexy, not obvious to the purchaser, and not a business that first-generation entrepreneurs typically think about. The vegetarian and HPMC capsule market is expanding more quickly than the domestic supply, due to the demand of halal, kosher and vegan consumers, which can’t be met by the gelatine capsule market. Get Detailed Project Report (DPR): Empty Gelatin Capsules Why This Is a Genuine Opening In this case, the demand reasons aren’t based on convincing anyone of anything. All tablet manufacturers making the move to capsule dosage, all new supplement brands from the nutraceutical industry, and every export order from Africa or Southeast Asia requires a dependable capsule supplier, but the supply base at home has not been able to keep up with the increase in formulation and nutraceutical manufacturing it feeds. There’s a special challenge for vegetarian HPMC capsules: consumers’ growing preference for plant-based shells for religious, dietary, and ethical reasons has created a shortage that’s exacerbated by the fact that only a few Indian manufacturers are currently producing HPMC capsules on a scale that meets demand. The entry cap-ex is not negligible. The cost of the single-line hard gelatin capsule unit, which is capable of producing about one billion to 1.5 billion capsules a year, is about eight to 15 crore rupees, involving investment in dip-pin machines, drying tunnels and printing equipment. The processing and drying conditions for the polymer used to make capsule lines are significantly different from those used in the case of gels and the lines are therefore more expensive, fifteen to twenty-five crore rupees. FSSAI registration is required for licensing and in case of export oriented pharmaceutical formulators, facility approval from CDSCO or USFDA clearance is required, which takes around twelve months of the commissioning process. Margin and Risk Structure This is because the commodity hard gelatin capsules is a thin margin business itself (gross margins are 8-12 percent) and because buyers change suppliers by fractions of a rupee per thousand capsules. The gross margin on HPMC vegetarian and specialty capsules is very high, anywhere from 18-25% gross margin, due to the fact that far fewer manufacturers can reliably produce these capsules to pharmacopeia specification, allowing the early movers to really have the pricing power that commodity gelatin manufacturers do not. In this segment, scalability typically comes from installing lines, not from building new facilities — a founder typically launches with a handful of dip-pin machines, tests out quality uniformity with a few formulation buyers, then expands lines based on repeat demand. The primary risks are raw material dependent; the price for gelatin is tied to the prices of bone and hide collagen on the global market, and is liable to sudden fluctuations, while HPMC is a derivative of cellulose, with a smaller and more concentrated global base of suppliers for its raw polymer. The other risk is rejection by quality-sensitive pharmaceutical buyers; if a buyer orders a year’s worth of sales but finds that one batch is out-of-specification, he or she may not order the next one. Product and Project Opportunities Worth Evaluating Standard Hard Gelatin Capsules The standard hard gelatin capsules are by far the biggest share of the market, providing generic pharmaceutical formulations to the overcrowded manufacturing camps in Baddi, Hyderabad and Ankleshwar in India. A unit designed to serve 1-1.5 billion capsules per year requires capex of ten to fourteen crore rupees, with an expectation of supplying companies in the formulation business within a radius of 300-400 kilometres to ensure cost of logistics. With the strong competition in the price of the existing large suppliers, it is obviously not a margin play that the new entrants can make the economics work with, but a business model based on volume and reliability. Gross margins finally settle at 8-12 percent. Related Article: Building a Successful Pharmaceutical Manufacturing Business HPMC Vegetarian Capsules For nutraceutical brands, halal and kosher export buyers, and pharmaceutical formulators seeking alternatives to animal-derived capsules, HPMC vegetarian capsules are the right choice. A dedicated line, which costs between a hundred and two crore rupees, accounting for the specialised polymer-processing and humidity-control specifications, directly targets nutraceutical contract manufacturers and export-based supplement brands. Margins are 18-24 % which is significantly better than gelatin, since there is very limited number of qualified HPMC capsule manufacturer in India till now with a growing demand. Colored and Printed Specialty Capsules Colored and custom printed capsules meet the brand differentiation needs of nutraceutical and consumer wellness companies looking to achieve a white shell that stands out on the shelf. Print and multi-colour capability is an additional cost of 2-4 crore rupees over the existing capsule line, margins are between 20-28 percent as the pricing is done based on brand value and not on the economics of capsules. A good second phase addition for an existing base gelatin or HPMC brand with a founder who does not want to invest in an additional facility for the higher margin brand-conscious consumers. Enteric-Coated Capsule Shells The enteric coated shells, which resist stomach acid and only open up in the intestine, appeal to a more niche but higher-value pharmaceutical and probiotic buyer segment. The additional cost of a specialised coating line at an existing capsule plant is of the order of Rs.5 to 8 crore, and margins are 25-30 per cent due to the technical barrier to entry, where the ability to replicate the coating consistency is a skill that